Clinical trial

Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally

NCT00408538

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-12-01

PhasePHASE1

Study timeline

Study start (unknown)2006-12-01Date precision: month

Registry last updated2009-05-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

UC-781 microbicide gel (0.1% and 0.25%)DRUG

placeboDRUG

Sponsors & collaborators

University of California, Los Angeleslead sponsor

National Institute of Allergy and Infectious Diseases (NIAID)collaborator

CONRADcollaborator

Mapped research locations

Los AngelesCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00408538 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.